Crossmark

Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial

Crossref DOI link: https://doi.org/10.1186/s12877-018-0814-3

Published Online: 2018-06-04

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lenssen, R.

Schmitz, K.

Griesel, C.

Heidenreich, A.

Schulz, J. B.

Trautwein, C.

Marx, N.

Fitzner, C.

Jaehde, U.

Eisert, A.
Funding

Funding for this research was provided by:

Foerderinitiative Pharmazeutische Betreuung e.V.

Apotheker-Stiftung Nordrhein
License Information

Text and Data Mining valid from 2018-06-04
More Information

Article History

Received: 30 August 2017

Accepted: 9 May 2018

First Online: 4 June 2018

Ethics approval and consent to participate

: The study was approved by the local ethics committee (ethic committee RWTH Aachen University, EK 195/12). Written informed consent was obtained from all individual participants or their legal representatives.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.